Baird downgraded Gilead Sciences (NASDAQ: GILD) from Outperform to Neutral.

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Downgrades Hot Downgrades

Goldman Sachs Boosts Gilead Sciences (GILD) Price TargetJuly 26, 2013 10:09 AM Gilead Sciences (GILD) Numbers Raised after Solid Qtr - Needham & CompanyJuly 26, 2013 8:12 AM Atlantic Equities Upgrades Gilead Sciences (GILD) to OverweightJuly 26, 2013 7:59 AM Gilead Sciences, Inc. (GILD) Reports In-Line Q2 EPSJuly 25, 2013 4:07 PM